Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells

Seung Hyun Kim, Sang Mi Oh, Ju Han Song, Dae Ho Cho, Quynh Manh Le, Suh Hee Lee, Won Jea Cho, Tae Sung Kim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Induction of differentiation is a new and promising approach to cancer therapy, well illustrated by the treatment of acute myeloid leukemia with all-trans retinoic acid (ATRA). Using combination of ATRA and chemotherapy, adverse effects such as retinoic acid syndrome have decreased, and long-term survival has improved. In this study, we demonstrated that the indeno[1,2-c]isoquinolines markedly enhanced differentiation of human myeloid leukemia HL-60 and NB4 cells when simultaneously combined with a low dose of ATRA. Of the tested compounds, 6-(4-methoxybenzyl)-2,11-dimethyl-6H,11H-indeno[1,2-c]isoquinolin-5-one (IIQ-16), an indeno[1,2-c]isoquinoline derivative, showed the highest differentiation-enhancing activity via a pathway involved with protein kinase C, extracellular signal-regulated kinase, and c-Jun N-terminal kinase. The ability to enhance the differentiation potential of ATRA by IIQ-16 may improve outcomes in the therapy of acute promyelocytic leukemia.

Original languageEnglish
Pages (from-to)1125-1132
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume16
Issue number3
DOIs
Publication statusPublished - 2008 Feb 1

Fingerprint

Isoquinolines
Myeloid Leukemia
Myeloid Cells
Tretinoin
Acute Promyelocytic Leukemia
Chemotherapy
JNK Mitogen-Activated Protein Kinases
HL-60 Cells
Extracellular Signal-Regulated MAP Kinases
Acute Myeloid Leukemia
Protein Kinase C
Therapeutics
Derivatives
Drug Therapy
Survival
Neoplasms

Keywords

  • All-trans retinoic acid
  • Differentiation
  • Indenoisoquinoline
  • Leukemia

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells. / Kim, Seung Hyun; Oh, Sang Mi; Song, Ju Han; Cho, Dae Ho; Le, Quynh Manh; Lee, Suh Hee; Cho, Won Jea; Kim, Tae Sung.

In: Bioorganic and Medicinal Chemistry, Vol. 16, No. 3, 01.02.2008, p. 1125-1132.

Research output: Contribution to journalArticle

Kim, Seung Hyun ; Oh, Sang Mi ; Song, Ju Han ; Cho, Dae Ho ; Le, Quynh Manh ; Lee, Suh Hee ; Cho, Won Jea ; Kim, Tae Sung. / Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells. In: Bioorganic and Medicinal Chemistry. 2008 ; Vol. 16, No. 3. pp. 1125-1132.
@article{48a6f4e22fc74c39a4f6bd846bb538cb,
title = "Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells",
abstract = "Induction of differentiation is a new and promising approach to cancer therapy, well illustrated by the treatment of acute myeloid leukemia with all-trans retinoic acid (ATRA). Using combination of ATRA and chemotherapy, adverse effects such as retinoic acid syndrome have decreased, and long-term survival has improved. In this study, we demonstrated that the indeno[1,2-c]isoquinolines markedly enhanced differentiation of human myeloid leukemia HL-60 and NB4 cells when simultaneously combined with a low dose of ATRA. Of the tested compounds, 6-(4-methoxybenzyl)-2,11-dimethyl-6H,11H-indeno[1,2-c]isoquinolin-5-one (IIQ-16), an indeno[1,2-c]isoquinoline derivative, showed the highest differentiation-enhancing activity via a pathway involved with protein kinase C, extracellular signal-regulated kinase, and c-Jun N-terminal kinase. The ability to enhance the differentiation potential of ATRA by IIQ-16 may improve outcomes in the therapy of acute promyelocytic leukemia.",
keywords = "All-trans retinoic acid, Differentiation, Indenoisoquinoline, Leukemia",
author = "Kim, {Seung Hyun} and Oh, {Sang Mi} and Song, {Ju Han} and Cho, {Dae Ho} and Le, {Quynh Manh} and Lee, {Suh Hee} and Cho, {Won Jea} and Kim, {Tae Sung}",
year = "2008",
month = "2",
day = "1",
doi = "10.1016/j.bmc.2007.10.086",
language = "English",
volume = "16",
pages = "1125--1132",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells

AU - Kim, Seung Hyun

AU - Oh, Sang Mi

AU - Song, Ju Han

AU - Cho, Dae Ho

AU - Le, Quynh Manh

AU - Lee, Suh Hee

AU - Cho, Won Jea

AU - Kim, Tae Sung

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Induction of differentiation is a new and promising approach to cancer therapy, well illustrated by the treatment of acute myeloid leukemia with all-trans retinoic acid (ATRA). Using combination of ATRA and chemotherapy, adverse effects such as retinoic acid syndrome have decreased, and long-term survival has improved. In this study, we demonstrated that the indeno[1,2-c]isoquinolines markedly enhanced differentiation of human myeloid leukemia HL-60 and NB4 cells when simultaneously combined with a low dose of ATRA. Of the tested compounds, 6-(4-methoxybenzyl)-2,11-dimethyl-6H,11H-indeno[1,2-c]isoquinolin-5-one (IIQ-16), an indeno[1,2-c]isoquinoline derivative, showed the highest differentiation-enhancing activity via a pathway involved with protein kinase C, extracellular signal-regulated kinase, and c-Jun N-terminal kinase. The ability to enhance the differentiation potential of ATRA by IIQ-16 may improve outcomes in the therapy of acute promyelocytic leukemia.

AB - Induction of differentiation is a new and promising approach to cancer therapy, well illustrated by the treatment of acute myeloid leukemia with all-trans retinoic acid (ATRA). Using combination of ATRA and chemotherapy, adverse effects such as retinoic acid syndrome have decreased, and long-term survival has improved. In this study, we demonstrated that the indeno[1,2-c]isoquinolines markedly enhanced differentiation of human myeloid leukemia HL-60 and NB4 cells when simultaneously combined with a low dose of ATRA. Of the tested compounds, 6-(4-methoxybenzyl)-2,11-dimethyl-6H,11H-indeno[1,2-c]isoquinolin-5-one (IIQ-16), an indeno[1,2-c]isoquinoline derivative, showed the highest differentiation-enhancing activity via a pathway involved with protein kinase C, extracellular signal-regulated kinase, and c-Jun N-terminal kinase. The ability to enhance the differentiation potential of ATRA by IIQ-16 may improve outcomes in the therapy of acute promyelocytic leukemia.

KW - All-trans retinoic acid

KW - Differentiation

KW - Indenoisoquinoline

KW - Leukemia

UR - http://www.scopus.com/inward/record.url?scp=38849090062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849090062&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2007.10.086

DO - 10.1016/j.bmc.2007.10.086

M3 - Article

C2 - 18024133

AN - SCOPUS:38849090062

VL - 16

SP - 1125

EP - 1132

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 3

ER -